Here, we report that Trop-2 mRNA and protein expression were similar across all demographic features examined with regard to patient and tumor baseline characteristics, including patient age, sex, and race, as well as NSCLC tumor histological subtype (adenocarcinoma and squamous cell carcinoma), stage, and clinically relevant driver alterations. The gene discussed is TACSTD2; the disease is adenocarcinoma.